Condition
Akathisia
Total Trials
4
Recruiting
0
Active
0
Completed
4
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
0%
0 of 4 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 3 (1)
Trial Status
Completed4
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT01942343Phase 3CompletedPrimary
Akathisia in Post Operative Outpatients Surgery
NCT01069536Not ApplicableCompletedPrimary
Efficacy and Akathisia Incidence of Slow Infusion Metoclopramide
NCT01051271Not ApplicableCompletedPrimary
Prophylaxis Against Metoclopramide-Induced Akathisia
NCT00065286CompletedPrimary
Akathisia (Restless Legs Syndrome) in People With Schizophrenia and Mental Retardation
Showing all 4 trials